Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-11.51%
↓ 144% vs avg
Percentile
P55
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
26.29%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -11.51% |
| Q2 2025 | 38.83% |
| Q1 2025 | 9.96% |
| Q4 2024 | -114.56% |
| Q3 2024 | 49.96% |
| Q2 2024 | 27.71% |
| Q1 2024 | -32.10% |
| Q4 2023 | -43.65% |
| Q3 2023 | -16.21% |
| Q2 2023 | 33.13% |
| Q1 2023 | -69.52% |
| Q4 2022 | -17.21% |
| Q3 2022 | -0.02% |
| Q2 2022 | 36.15% |
| Q1 2022 | -60.60% |
| Q4 2021 | -68.97% |
| Q3 2021 | -72.24% |
| Q2 2021 | 56.98% |
| Q1 2021 | -20.10% |
| Q4 2020 | -262.56% |
| Q3 2020 | -101.74% |
| Q2 2020 | -484.77% |
| Q1 2020 | -144.34% |
| Q4 2019 | -50.13% |
| Q3 2019 | 796.90% |
| Q2 2019 | 68.55% |
| Q1 2019 | -147.55% |
| Q4 2018 | 1388.22% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |